第一单位：
Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.;Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
作者：
Yuta,Ito [1]
;
Amira,Marouf [2]
;
Yasunori,Kogure [3]
;
Junji,Koya [3]
;
Raphaël,Liévin [2]
;
Julie,Bruneau [4]
;
Mariko,Tabata [5]
;
Yuki,Saito [6]
;
Sumito,Shingaki [3]
;
Mitsuhiro,Yuasa [7]
;
Kentaro,Yamaguchi [8]
;
Koichi,Murakami [8]
;
Robert,Weil [9]
;
Manon,Vavasseur [2]
;
Guillaume P,Andrieu [10]
;
Mehdi,Latiri [10]
;
Layla,Veleanu [10]
;
Michaël,Dussiot [2]
;
Isabelle,André [11]
;
Akshay,Joshi [11]
;
Chantal,Lagresle-Peyrou [12]
;
Aude,Magerus [13]
;
Sammara,Chaubard [14]
;
David,Lavergne [14]
;
Emmanuel,Bachy [15]
;
Erika,Brunet [16]
;
Virginie,Fataccioli [17]
;
Chantal,Brouzes [10]
;
Camille,Laurent [18]
;
Laurence,de Leval [19]
;
Alexandra,Traverse-Glehen [20]
;
Céline,Bossard [21]
;
Marie,Parrens [22]
;
Véronique,Meignin [23]
;
Laure,Philippe [24]
;
Julien,Rossignol [25]
;
Felipe,Suarez [25]
;
Jean-Marie,Michot [26]
;
Olivier,Tournilhac [27]
;
Gandhi,Damaj [28]
;
François,Lemonnier [29]
;
Christine,Bôle-Feysot [30]
;
Patrick,Nitschké [31]
;
Bruno,Tesson [32]
;
Cécile,Laurent [32]
;
Thierry,Molina [4]
;
Vahid,Asnafi [10]
;
Yosaku,Watatani [33]
;
Kenichi,Chiba [34]
;
Ai,Okada [34]
;
Yuichi,Shiraishi [34]
;
Sachiko,Tsukita [35]
;
Koji,Izutsu [36]
;
Hiroaki,Miyoshi [37]
;
Koichi,Ohshima [37]
;
Seiji,Sakata [38]
;
Akito,Dobashi [38]
;
Kengo,Takeuchi [38]
;
Masashi,Sanada [39]
;
Philippe,Gaulard [17]
;
Arnaud,Jaccard [14]
;
Seishi,Ogawa [40]
;
Olivier,Hermine [25]
;
Keisuke,Kataoka [8]
;
Lucile,Couronné [41]
作者单位：
Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.;Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
[1]
Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Université Paris Cité, Paris, France.
[2]
Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.
[3]
Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Université Paris Cité, Paris, France.;Pathology Department, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.
[4]
Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.;Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
[5]
Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.;Department of Gastroenterology, Keio University School of Medicine, Tokyo, Japan.
[6]
Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.;Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
[7]
Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.;Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
[8]
Sorbonne Universités, Institut National de la Santé et de la Recherche Médiicale (INSERM, UMR1135), Centre National de la Recherche Scientifique (CNRS, ERL8255), Centre d'Immunologie et des Maladies Infectieuses CMI, Paris, France.
[9]
INSERM UMR_S 1151, Necker Enfants Malades Institute (INEM), Université Paris Cité, Paris, France.;Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.
[10]
Human Lymphohematopoiesis Lab, Université Paris Cité, Imagine Institute, INSERM UMR_S 1163, Paris, France.
[11]
Biotherapy Clinical Investigation Center, Université Paris Cité, Imagine Institute, INSERM CIC 1416, Assistance Publique-Hopitaux de Paris, Paris, France.
[12]
Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Université Paris Cité, Imagine Institute, INSERM UMR_S 1163, Paris, France.
[13]
Hematology Department, Limoges University Hospital, Limoges, France.
[14]
Hematology Department, Lyon Civils Hospices, Lyon, France.;Lymphoma Immuno-Biology (LIB) Team, Université Claude Bernard Lyon 1, Lyon, France.
[15]
Laboratory of the Genome Dynamics in the Immune System, Équipe Labéllisée La Ligue Contre Le Cancer, Université Paris Cité, Paris Saclay University, INSERM UMR_S 1163, Imagine Institute, Paris, France.
[16]
Pathology Department, Henri Mondor University Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Créteil, France.;INSERM U955, Mondor Institute for Biomedical Research, Paris-Est Créteil University, Créteil, France.
[17]
Department of Pathology, Cancer University Institute of Toulouse Oncopole, Toulouse, France.;Cancer Research Center of Toulouse, INSERM UMR 1037, ERL5294 CNRS, Toulouse III-Paul-Sabatier University, Toulouse, France.
[18]
Department of Laboratory Medicine and Pathology, Institute of Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland.
[19]
Department of Pathology, Lyon Sud Hospital, Claude Bernard Lyon-1 University, Pierre-Bénite, France.
[20]
Department of Pathology, Nantes University Hospital, Nantes, France.
[21]
Department of Pathology, Bordeaux University Hospital, Bordeaux University, Bordeaux, France.
[22]
Pathology Department, Saint Louis Hospital, Université Paris Cité, Paris, France.
[23]
Department of Hematology, Annecy Genevois Hospital, Epagny Metz-Tessy, France.
[24]
Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Université Paris Cité, Paris, France.;Hematology Department, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.
[25]
Drug Development Department, Gustave Roussy Institute, Paris-Saclay University, Villejuif, France.
[26]
Department of Hematology, Clermont-Ferrand University Hospital, Clermont Auvergne University, Clermont-Ferrand, France.
[27]
Department of Hematology, Caen University Hospital, Normandy University, Caen, France.
[28]
INSERM U955, Mondor Institute for Biomedical Research, Paris-Est Créteil University, Créteil, France.;Hematology Department, Henri Mondor University Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Créteil, France.
[29]
Genomics Core Facility, Imagine Institute-SFR Necker, INSERM U1163 and INSERM US24/CNRS UAR3633, Université Paris Cité, Paris, France.
[30]
INSERM UMR_S 1163, Bioinformatics Platform, Imagine Institute, Université Paris Cité, Paris, France.
[31]
Bioinformatics Department, LYSARC, Pierre-Bénite, France.
[32]
Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
[33]
Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan.
[34]
Advanced Comprehensive Research Organization (ACRO), Teikyo University, Tokyo, Japan.
[35]
Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.;Department of Hematology, Toranomon Hospital, Tokyo, Japan.
[36]
Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
[37]
Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.;Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.;Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
[38]
Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
[39]
Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.;Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan.;Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden.
[40]
Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutic Implications, INSERM UMR_S 1163, Imagine Institute, Université Paris Cité, Paris, France.;Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.
[41]
医学主题词
人类(Humans);男(雄)性(Male);女(雌)性(Female);染色体, 人, X(Chromosomes, Human, X);淋巴瘤, 结外NK-T细胞(Lymphoma, Extranodal NK-T-Cell);DNA拷贝数变异(DNA Copy Number Variations);突变(Mutation);中年人(Middle Aged);动物(Animals);成年人(Adult);小鼠(Mice);预后(Prognosis);老年人(Aged);基因表达谱(Gene Expression Profiling);细胞系, 肿瘤(Cell Line, Tumor);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);青年人(Young Adult);爱泼斯坦巴尔病毒感染(Epstein-Barr Virus Infections)
DOI
10.1158/0008-5472.CAN-24-0132
PMID
38657099
发布时间
2024-07-31
换一批
